Thus, differences between AML patients with regard to Cx45 expression at the mRNA level in leukemia cells are associated with additional differences with regard to intra- and extracellular signaling, as well as the regulation of protein function. This evidence concerns the gene GJC1 and acute myeloid leukemia.